Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Follow-up
NCT00149929Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 1999
- Primary completion
- Apr 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Dec 1999; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00149929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149929.